{"gene":"SLITRK3","run_date":"2026-04-28T20:42:08","timeline":{"discoveries":[{"year":2012,"finding":"Slitrk3 functions as a postsynaptic adhesion molecule that selectively regulates inhibitory synapse development through trans-synaptic interaction with axonal PTPδ. When expressed in fibroblasts, Slitrk3 triggered inhibitory presynaptic differentiation in contacting axons. Recombinant Slitrk3 preferentially localized to inhibitory postsynaptic sites. Slitrk3-deficient mice showed decreased inhibitory (but not excitatory) synapse number and function in hippocampal CA1 neurons, and increased seizure susceptibility.","method":"Heterologous cell co-culture synaptogenesis assay, immunostaining, Slitrk3 KO mouse analysis, electrophysiology, recombinant protein localization","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (cell assay, KO mouse, electrophysiology, localization) in a single high-impact study, foundational paper","pmids":["22286174"],"is_preprint":false},{"year":2003,"finding":"Slitrk3, as a member of the Slitrk family, is an integral membrane protein with two extracellular leucine-rich repeat (LRR) domains homologous to Slit proteins and an intracellular domain partially homologous to Trk neurotrophin receptors. Overexpression of Slitrk2 and other Slitrk proteins (including Slitrk3) inhibited neurite outgrowth in cultured neuronal cells, with the functional difference between Slitrk1 and Slitrk2–6 residing in their intracellular domains.","method":"Overexpression in cultured neuronal cells, deletion analysis of intracellular domains, domain homology characterization","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 — direct functional assay with deletion analysis, single lab","pmids":["14550773"],"is_preprint":false},{"year":2013,"finding":"Slitrks, including Slitrk3, are enriched in postsynaptic densities in rat brains. Slitrk3 requires PTPδ (not PTPσ) to trigger inhibitory synapse formation, establishing isoform-specific LAR-RPTP pairing: PTPσ mediates excitatory and PTPδ mediates inhibitory synaptogenesis by Slitrks. RNAi-mediated knockdown of Slitrks decreased synapse density.","method":"Subcellular fractionation, overexpression/RNAi knockdown in neurons, co-culture synaptogenesis assay with LAR-RPTP isoforms","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple methods (fractionation, KD, OE, co-culture), independent replication of Slitrk3-PTPδ specificity","pmids":["23345436"],"is_preprint":false},{"year":2017,"finding":"Neuroligin 2 (NL2) and Slitrk3 (ST3) interact directly through their extracellular domains with nanomolar affinity in a cis fashion at postsynaptic inhibitory sites. During neuronal maturation, both NL2 and ST3 are required and act synergistically to promote GABAergic synapse development. Selective perturbation of the NL2-ST3 interaction impairs inhibitory synapse development, disrupts hippocampal network activity, and increases seizure susceptibility.","method":"Binding affinity measurements, co-immunoprecipitation, hippocampal neuron culture assays, electrophysiology, in vivo seizure susceptibility testing","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical binding assay plus multiple cellular and in vivo functional readouts, strong mechanistic dissection","pmids":["29107521"],"is_preprint":false},{"year":2017,"finding":"LAR-RPTP binding to postsynaptic adhesion ligands including Slitrk3 induces reciprocal higher-order clustering of trans-synaptic adhesion complexes. The crystal structure of the human LAR-RPTP/IL1RAPL1 complex revealed that lateral interactions between neighboring complexes are critical for higher-order assembly and synaptogenic activity. Heparan sulfate (HS) can competitively dismantle pre-established LAR-RPTP–Slitrk3 trans-synaptic complexes.","method":"Crystal structure determination, synaptogenesis assay, clustering assay","journal":"Frontiers in molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 1–2 — structural data plus functional clustering assay, single study","pmids":["29081732"],"is_preprint":false},{"year":2019,"finding":"The conserved tyrosine residue Y969 in the Slitrk3 carboxyl (C)-terminus is critical for GABAergic synapse development in hippocampal neurons. ST3 C-terminus is not required for homo-dimerization or cell-surface trafficking in heterologous cells. In neurons, the Y969A mutant failed to rescue GABAergic transmission deficits in ST3-deleted neurons and markedly reduced gephyrin puncta density.","method":"Site-directed mutagenesis, overexpression in hippocampal neurons, single-cell genetic deletion (rescue experiment), electrophysiology, immunostaining","journal":"Frontiers in molecular neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis with defined single-residue functional readout, rescue experiment with KO neurons, multiple complementary methods","pmids":["31551708"],"is_preprint":false},{"year":2021,"finding":"Slitrk3 stabilization at GABAergic synapses during development requires interaction with gephyrin. Protein kinase A–mediated phosphorylation of gephyrin on serine 303 (downstream of GABAAR and A2AR signaling) is required for GABAAR stabilization, and gephyrin–Slitrk3 interaction is involved in the stabilization of both pre- and postsynaptic GABAergic elements.","method":"Pharmacological activation/blockade of GABAAR and A2AR, biochemical interaction assays, phosphomutant analysis, imaging of synapse stabilization/elimination","journal":"Science (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 — interaction and phosphorylation assay with functional consequence, single study for gephyrin-Slitrk3 interaction specifically","pmids":["34735259"],"is_preprint":false},{"year":2021,"finding":"ErbB4, via its extracellular RLD domain, interacts in trans with Slitrk3 at inhibitory synapses in a kinase-independent manner to promote inhibitory synapse formation onto pyramidal neurons. Disruption of ErbB4-Slitrk3 interaction (using secretable RLD) decreased inhibitory synapses onto pyramidal neurons and impaired GABAergic transmission.","method":"Co-culture HEK293T/neuron synaptogenesis assay, co-immunoprecipitation, kinase-dead knock-in mice, neutralization with secretable RLD domain, electrophysiology","journal":"Translational psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus functional co-culture assay and in vivo mouse data, single lab","pmids":["34226493"],"is_preprint":false},{"year":2021,"finding":"SLITRK3 activates NTRK3 in lung squamous cell carcinoma (LUSC) cells to promote a cancer stem cell phenotype. Gene amplification drives high SLITRK3 expression in LUSC, and SLITRK3-dependent NTRK3 activation is inhibited by NTRK-targeted inhibitors, reducing the CD133-positive cancer stem cell fraction.","method":"In situ immunofluorescence, sphere-formation assay, FACS (CD133+ fraction), copy number and expression analysis of patient datasets","journal":"Molecular biomedicine","confidence":"Low","confidence_rationale":"Tier 3 — functional cancer cell assays but mechanism of NTRK3 activation not biochemically resolved, single lab","pmids":["35006496"],"is_preprint":false},{"year":2024,"finding":"Biallelic loss-of-function variants (C566R, E606X) in SLITRK3 cause epileptic encephalopathy with microcephaly, intellectual disability, and seizures. C566R and E606X mutations alter SLITRK3 cell-surface expression, causing protein accumulation in the Golgi apparatus. Primary hippocampal neurons carrying patient variants show impaired GABAergic transmission by electrophysiology. SLITRK3 KO mice exhibit spontaneous epileptiform EEG activity, enhanced seizure susceptibility, and reduced parvalbumin interneurons.","method":"Immunostaining in HEK-293 cells, primary hippocampal neuron cultures with patient variants, electrophysiology (mIPSC recording), EEG recording in KO mice, pentylenetetrazole seizure threshold assay","journal":"Frontiers in molecular neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — patient variant functional characterization with multiple orthogonal methods (cell biology, electrophysiology, in vivo EEG), replicated in both human cell and mouse models","pmids":["38495551"],"is_preprint":false}],"current_model":"SLITRK3 is a postsynaptic transmembrane cell adhesion molecule that selectively organizes inhibitory (GABAergic) synapse development by forming a trans-synaptic complex with presynaptic PTPδ and a cis-interaction with postsynaptic Neuroligin 2; its conserved intracellular tyrosine Y969 is required for synapse function, its extracellular domain also mediates interactions with ErbB4, gephyrin stabilization links it to activity-dependent synapse maintenance, and loss-of-function mutations in humans cause epileptic encephalopathy."},"narrative":{"teleology":[{"year":2003,"claim":"Identification of SLITRK3 as a neuronal transmembrane protein with Slit-like LRR and Trk-like intracellular domains established that the Slitrk family can regulate neurite outgrowth, with functional specificity mapping to the intracellular domain.","evidence":"Overexpression and deletion analysis in cultured neuronal cells","pmids":["14550773"],"confidence":"Medium","gaps":["Neurite outgrowth phenotype was shown for Slitrk2 primarily; SLITRK3-specific effect inferred from family membership","Synaptic role not yet explored","Endogenous binding partners unknown"]},{"year":2012,"claim":"The discovery that SLITRK3 selectively promotes inhibitory synapse formation via trans-synaptic interaction with PTPδ, and that knockout mice show reduced inhibitory synapses and seizure susceptibility, established SLITRK3 as the first synapse organizer with specificity for inhibitory synapses.","evidence":"Heterologous co-culture synaptogenesis assay, immunostaining, Slitrk3 KO mice, electrophysiology","pmids":["22286174"],"confidence":"High","gaps":["Structural basis of PTPδ selectivity unresolved","Postsynaptic signaling downstream of SLITRK3 unknown","Whether other postsynaptic partners contribute not tested"]},{"year":2013,"claim":"Independent confirmation that SLITRK3 specifically requires PTPδ (not PTPσ) for inhibitory synaptogenesis, combined with the finding that Slitrks are enriched in postsynaptic densities, solidified the isoform-specific LAR-RPTP pairing model for excitatory versus inhibitory synapse specification.","evidence":"Subcellular fractionation, overexpression/RNAi in neurons, co-culture with LAR-RPTP isoforms","pmids":["23345436"],"confidence":"High","gaps":["Molecular determinants within PTPδ that confer SLITRK3 specificity not mapped","Role of PTPδ phosphatase activity in downstream signaling unclear"]},{"year":2017,"claim":"Two advances revealed the combinatorial logic of inhibitory synapse assembly: SLITRK3 forms a cis-complex with Neuroligin 2 that synergistically drives GABAergic synaptogenesis, and the trans-synaptic LAR-RPTP–ligand complexes undergo higher-order clustering essential for synaptogenic activity, with heparan sulfate capable of dismantling SLITRK3–PTPδ complexes.","evidence":"Binding affinity measurements, co-immunoprecipitation, hippocampal neuron cultures, electrophysiology, in vivo seizure testing, crystal structure and clustering assays","pmids":["29107521","29081732"],"confidence":"High","gaps":["Structural basis of the NL2–SLITRK3 cis-interaction not determined","In vivo relevance of heparan sulfate-mediated complex disassembly untested","Stoichiometry and dynamics of higher-order assemblies at native synapses unknown"]},{"year":2019,"claim":"Identification of Y969 as a critical intracellular residue for GABAergic synapse function linked SLITRK3's postsynaptic signaling capacity to gephyrin scaffold assembly, showing the C-terminus is dispensable for surface trafficking but essential for synaptic rescue.","evidence":"Site-directed mutagenesis, single-cell KO rescue in hippocampal neurons, electrophysiology, immunostaining","pmids":["31551708"],"confidence":"High","gaps":["Kinase responsible for Y969 phosphorylation not identified","Direct binding partners of the SLITRK3 intracellular domain beyond gephyrin not characterized"]},{"year":2021,"claim":"Three parallel discoveries expanded the SLITRK3 interaction network and its regulation: gephyrin–SLITRK3 interaction stabilizes GABAergic synapses downstream of PKA-mediated gephyrin S303 phosphorylation; ErbB4 provides a kinase-independent trans-synaptic input through its RLD domain to promote inhibitory synaptogenesis; and in a non-neuronal context, SLITRK3 gene amplification in lung squamous cell carcinoma activates NTRK3 to support a cancer stem cell phenotype.","evidence":"Pharmacological and phosphomutant assays for gephyrin interaction; co-culture, co-IP, kinase-dead knock-in mice for ErbB4; sphere-formation and FACS for cancer phenotype","pmids":["34735259","34226493","35006496"],"confidence":"Medium","gaps":["Gephyrin–SLITRK3 binding interface not structurally resolved","ErbB4–SLITRK3 interaction confirmed in single lab; reciprocal in vivo genetic validation pending","NTRK3 activation mechanism by SLITRK3 in cancer cells not biochemically defined; single study with low mechanistic resolution"]},{"year":2024,"claim":"Biallelic SLITRK3 loss-of-function variants (C566R, E606X) were shown to cause epileptic encephalopathy with microcephaly, directly linking impaired SLITRK3 surface trafficking and GABAergic transmission deficits to human disease; KO mice recapitulated epileptiform activity and reduced parvalbumin interneuron numbers.","evidence":"Patient variant functional characterization in HEK-293 cells and primary neurons, mIPSC recording, EEG in KO mice, PTZ seizure threshold assay","pmids":["38495551"],"confidence":"High","gaps":["Number of patient families is small; broader genotype–phenotype spectrum not yet defined","Whether C566R retains partial function or is fully null not resolved","Mechanism linking SLITRK3 loss to reduced parvalbumin interneuron count (cell death vs. differentiation failure) unknown"]},{"year":null,"claim":"Key unresolved questions include the identity of the kinase(s) phosphorylating Y969, the structural basis of the NL2–SLITRK3 cis-complex, how SLITRK3 signals intracellularly to recruit gephyrin, and whether therapeutic rescue of GABAergic transmission is feasible in SLITRK3-associated epileptic encephalopathy.","evidence":"","pmids":[],"confidence":"High","gaps":["No kinase for Y969 identified","No crystal or cryo-EM structure of SLITRK3 intracellular domain or NL2–SLITRK3 cis-complex","Therapeutic strategies for SLITRK3 deficiency not explored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,2,3]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,2,9]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[9]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,2,3,5,6]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[0,3,7]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,6,7]}],"complexes":[],"partners":["PTPRD","NLGN2","ERBB4","GPHN"],"other_free_text":[]},"mechanistic_narrative":"SLITRK3 is a postsynaptic transmembrane adhesion molecule that selectively promotes GABAergic (inhibitory) synapse development and maintenance. Its extracellular leucine-rich repeat domains engage presynaptic PTPδ in trans to trigger inhibitory presynaptic differentiation, while a cis-interaction with Neuroligin 2 at nanomolar affinity synergistically drives inhibitory synapse assembly; heparan sulfate can competitively dismantle the PTPδ–SLITRK3 complex, and ErbB4 provides an additional trans-synaptic input that promotes inhibitory synaptogenesis onto pyramidal neurons [PMID:22286174, PMID:23345436, PMID:29107521, PMID:34226493, PMID:29081732]. Intracellularly, the conserved tyrosine Y969 is required for GABAergic transmission and gephyrin scaffold stabilization, linking activity-dependent PKA-mediated gephyrin phosphorylation to the maintenance of both pre- and postsynaptic inhibitory elements [PMID:31551708, PMID:34735259]. Biallelic loss-of-function SLITRK3 variants cause epileptic encephalopathy with microcephaly, consistent with impaired GABAergic transmission and reduced parvalbumin interneuron numbers observed in SLITRK3 knockout mice [PMID:38495551]."},"prefetch_data":{"uniprot":{"accession":"O94933","full_name":"SLIT and NTRK-like protein 3","aliases":[],"length_aa":977,"mass_kda":108.9,"function":"Suppresses neurite outgrowth","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/O94933/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLITRK3","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLITRK3","total_profiled":1310},"omim":[{"mim_id":"609679","title":"SLIT- AND NTRK-LIKE FAMILY, MEMBER 3; SLITRK3","url":"https://www.omim.org/entry/609679"},{"mim_id":"601598","title":"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, DELTA; PTPRD","url":"https://www.omim.org/entry/601598"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":9.3},{"tissue":"fallopian tube","ntpm":13.0}],"url":"https://www.proteinatlas.org/search/SLITRK3"},"hgnc":{"alias_symbol":["KIAA0848"],"prev_symbol":[]},"alphafold":{"accession":"O94933","domains":[{"cath_id":"3.80.10.10","chopping":"50-208","consensus_level":"high","plddt":90.3515,"start":50,"end":208},{"cath_id":"3.80.10.10","chopping":"381-513","consensus_level":"high","plddt":88.9492,"start":381,"end":513}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O94933","model_url":"https://alphafold.ebi.ac.uk/files/AF-O94933-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O94933-F1-predicted_aligned_error_v6.png","plddt_mean":63.78},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLITRK3","jax_strain_url":"https://www.jax.org/strain/search?query=SLITRK3"},"sequence":{"accession":"O94933","fasta_url":"https://rest.uniprot.org/uniprotkb/O94933.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O94933/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O94933"}},"corpus_meta":[{"pmid":"24821223","id":"PMC_24821223","title":"Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS.","date":"2014","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/24821223","citation_count":230,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22286174","id":"PMC_22286174","title":"Selective control of inhibitory synapse development by Slitrk3-PTPδ trans-synaptic interaction.","date":"2012","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22286174","citation_count":206,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14557068","id":"PMC_14557068","title":"Human SLITRK family genes: genomic organization and expression profiling in normal brain and brain tumor tissue.","date":"2003","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/14557068","citation_count":119,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29107521","id":"PMC_29107521","title":"Molecular Dissection of Neuroligin 2 and Slitrk3 Reveals an Essential Framework for GABAergic Synapse Development.","date":"2017","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/29107521","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34735259","id":"PMC_34735259","title":"Convergence of adenosine and GABA signaling for synapse stabilization during development.","date":"2021","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/34735259","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29081732","id":"PMC_29081732","title":"LAR-RPTP Clustering Is Modulated by Competitive Binding between Synaptic Adhesion Partners and Heparan Sulfate.","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29081732","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34226493","id":"PMC_34226493","title":"ErbB4 promotes inhibitory synapse formation by cell adhesion, independent of its kinase activity.","date":"2021","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/34226493","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37904697","id":"PMC_37904697","title":"Cerebrospinal fluid proteomics in meningitis patients with reactivated varicella zoster virus.","date":"2023","source":"Immunity, inflammation and disease","url":"https://pubmed.ncbi.nlm.nih.gov/37904697","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28035996","id":"PMC_28035996","title":"Novel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2-8) in Normal and Cancerous Breast and Prostate Cells.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28035996","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35006496","id":"PMC_35006496","title":"Role of novel cancer gene SLITRK3 to activate NTRK3 in squamous cell lung cancer.","date":"2021","source":"Molecular biomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/35006496","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38942348","id":"PMC_38942348","title":"The Contribution of Mosaic Chromosomal Alterations to Schizophrenia.","date":"2024","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/38942348","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31551708","id":"PMC_31551708","title":"A Conserved Tyrosine Residue in Slitrk3 Carboxyl-Terminus Is Critical for GABAergic Synapse Development.","date":"2019","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31551708","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38495551","id":"PMC_38495551","title":"Human mutations in SLITRK3 implicated in GABAergic synapse development in mice.","date":"2024","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/38495551","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37453139","id":"PMC_37453139","title":"Transcriptomic analysis of ovarian follicles uncovers the crucial genes relevant to follicle selection and preovulatory hierarchy in hens.","date":"2023","source":"Journal of animal science","url":"https://pubmed.ncbi.nlm.nih.gov/37453139","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29144966","id":"PMC_29144966","title":"GABAergic Synaptogenesis: A Case for Cooperation.","date":"2017","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/29144966","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39216827","id":"PMC_39216827","title":"New insights into potential biomarkers and their roles in biological processes associated with hepatitis C-related liver cirrhosis by hepatic RNA-seq-based transcriptome profiling.","date":"2024","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/39216827","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39979466","id":"PMC_39979466","title":"Exploring the early drivers of pain in Parkinson's disease.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39979466","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41516028","id":"PMC_41516028","title":"Endometriosis: From Genes to Global Burden.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41516028","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40213228","id":"PMC_40213228","title":"Advancement in medical treatment for gastrointestinal stromal tumors (GISTs): a ray of hope.","date":"2024","source":"Annals of medicine and surgery (2012)","url":"https://pubmed.ncbi.nlm.nih.gov/40213228","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27565350","id":"PMC_27565350","title":"Proteomic Analysis of Unbounded Cellular Compartments: Synaptic Clefts.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/27565350","citation_count":333,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28611215","id":"PMC_28611215","title":"Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28611215","citation_count":282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10048485","id":"PMC_10048485","title":"Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.","date":"1998","source":"DNA research : an international journal for rapid publication of reports on genes and genomes","url":"https://pubmed.ncbi.nlm.nih.gov/10048485","citation_count":190,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14550773","id":"PMC_14550773","title":"Identification and characterization of Slitrk, a novel neuronal transmembrane protein family controlling neurite outgrowth.","date":"2003","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/14550773","citation_count":183,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23345436","id":"PMC_23345436","title":"Slitrks control excitatory and inhibitory synapse formation with LAR receptor protein tyrosine phosphatases.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23345436","citation_count":155,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31871319","id":"PMC_31871319","title":"Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31871319","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30639242","id":"PMC_30639242","title":"The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.","date":"2019","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30639242","citation_count":124,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28065597","id":"PMC_28065597","title":"A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28065597","citation_count":102,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30021884","id":"PMC_30021884","title":"Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry in Intact Cell Nuclei.","date":"2018","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/30021884","citation_count":101,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32814053","id":"PMC_32814053","title":"Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32814053","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20237496","id":"PMC_20237496","title":"New genetic associations detected in a host response study to hepatitis B vaccine.","date":"2010","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/20237496","citation_count":69,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29987050","id":"PMC_29987050","title":"Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29987050","citation_count":59,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35384245","id":"PMC_35384245","title":"Physical and functional interactome atlas of human receptor tyrosine kinases.","date":"2022","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/35384245","citation_count":50,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31391242","id":"PMC_31391242","title":"DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy.","date":"2019","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/31391242","citation_count":25,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26217092","id":"PMC_26217092","title":"SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.","date":"2015","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/26217092","citation_count":17,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34687211","id":"PMC_34687211","title":"SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration.","date":"2021","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/34687211","citation_count":16,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19336002","id":"PMC_19336002","title":"The PcG protein hPc2 interacts with the N-terminus of histone demethylase JARID1B and acts as a transcriptional co-repressor.","date":"2009","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/19336002","citation_count":12,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11252,"output_tokens":2589,"usd":0.036296},"stage2":{"model":"claude-opus-4-6","input_tokens":5892,"output_tokens":2310,"usd":0.130815},"total_usd":0.364347,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":20321,"output_tokens":2848,"usd":0.051841},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6451,"output_tokens":2587,"usd":0.145395}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"Slitrk3 acts as a postsynaptic adhesion molecule that selectively induces inhibitory (GABAergic) presynaptic differentiation via trans-synaptic interaction with axonal receptor protein tyrosine phosphatase PTPδ. When expressed in fibroblasts, Slitrk3 triggered only inhibitory presynaptic differentiation in contacting axons of co-cultured rat hippocampal neurons. Recombinant Slitrk3 preferentially localized to inhibitory postsynaptic sites. Slitrk3-deficient mice showed decreased inhibitory synapse number and function in hippocampal CA1 neurons, increased seizure susceptibility, and spontaneous epileptiform activity.\",\n      \"method\": \"Heterologous cell co-culture synaptogenesis assay, recombinant protein localization, Slitrk3 knockout mouse analysis (electrophysiology, immunostaining, EEG)\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (co-culture assay, KO mouse with defined cellular phenotype, electrophysiology, localization), strong mechanistic evidence from single study\",\n      \"pmids\": [\"22286174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Neuroligin 2 (NL2) and Slitrk3 interact through their extracellular domains with nanomolar affinity in cis at postsynaptic inhibitory sites, working synergistically to promote GABAergic synapse development. NL2 is required for establishing GABAergic transmission in developing neurons, while both NL2 and Slitrk3 are required during maturation. Selective perturbation of the NL2-Slitrk3 interaction impairs inhibitory synapse development and increases seizure susceptibility.\",\n      \"method\": \"Binding affinity measurements (nanomolar Kd), domain-mapping mutagenesis, co-culture synaptogenesis assay, electrophysiology in hippocampal neurons, in vivo seizure susceptibility assay\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical binding assay plus multiple orthogonal functional assays with defined cellular and in vivo phenotypes\",\n      \"pmids\": [\"29107521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LAR-RPTP binding to Slitrk3 (along with IL1RAPL1 and IL-1RAcP, but not TrkC) induces reciprocal higher-order clustering of trans-synaptic adhesion complexes. Dominant binding of heparan sulfate to LAR-RPTP can dismantle pre-established LAR-RPTP/Slitrk3-mediated trans-synaptic adhesion complexes.\",\n      \"method\": \"Crystal structure of LAR-RPTP/IL1RAPL1 complex, clustering assay with postsynaptic adhesion ligands including Slitrk3\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — structural data combined with functional clustering assay, but Slitrk3 is one of several ligands tested\",\n      \"pmids\": [\"29081732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The conserved tyrosine residue Y969 in the Slitrk3 carboxyl-terminus is critical for GABAergic synapse development. The C-terminus is not required for Slitrk3 homo-dimerization or cell surface trafficking in heterologous cells, but in hippocampal neurons the Y969A mutant markedly reduces gephyrin puncta density and GABAergic transmission, and fails to rescue GABAergic transmission deficits in ST3-knockout neurons.\",\n      \"method\": \"Site-directed mutagenesis (Y969A), heterologous cell surface trafficking assay, overexpression and single-cell genetic deletion in hippocampal neurons, electrophysiology\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis with functional rescue experiment, multiple readouts (immunostaining, electrophysiology)\",\n      \"pmids\": [\"31551708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Gephyrin interacts with Slitrk3 to stabilize GABAergic synaptic elements during development. Protein kinase A, activated via GABAAR and A2AR signaling, phosphorylates gephyrin at serine 303, which is required for GABAAR stabilization; gephyrin-Slitrk3 interaction is involved in stabilizing both pre- and postsynaptic GABAergic elements.\",\n      \"method\": \"Co-immunoprecipitation/interaction assay between gephyrin and Slitrk3, pharmacological manipulation of PKA pathway, phosphomutant analysis (gephyrin S303)\",\n      \"journal\": \"Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — interaction between gephyrin and Slitrk3 shown in context of broader pathway study with pharmacological and mutagenesis evidence\",\n      \"pmids\": [\"34735259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ErbB4 interacts in trans with Slitrk3 through the extracellular RLD domain of ErbB4, promoting inhibitory synapse formation onto pyramidal neurons in a kinase-independent manner. Deletion of the RLD domain abolished ErbB4-mediated induction of gephyrin/GABAAR α1 puncta; neutralization of Slitrk3 by secretable RLD decreased inhibitory synapses and impaired GABAergic transmission.\",\n      \"method\": \"Co-culture synaptogenesis assay (HEK293T cells + hippocampal neurons), domain deletion mutagenesis (ΔRLD), ErbB4 kinase-dead knock-in mice, Slitrk3 neutralization experiment, electrophysiology\",\n      \"journal\": \"Translational psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — domain mapping mutagenesis, kinase-dead knock-in mice, neutralization rescue, multiple orthogonal methods in single study\",\n      \"pmids\": [\"34226493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SLITRK3 activates NTRK3 (TrkC) signaling in lung squamous cell carcinoma cells, promoting a cancer stem cell phenotype (increased CD133-positive fraction, sphere-forming ability) that is inhibited by NTRK-targeted inhibitors.\",\n      \"method\": \"In situ immunofluorescence, sphere-formation assay, FACS analysis of CD133+ fraction, NTRK inhibitor treatment in LUSC cell lines\",\n      \"journal\": \"Molecular biomedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — cellular assays in cancer cell lines with pharmacological inhibition, single lab study\",\n      \"pmids\": [\"35006496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Human pathogenic variants in SLITRK3 (C566R and E606X) cause protein mislocalization and accumulation in the Golgi apparatus rather than proper cell-surface expression. In hippocampal neurons carrying these variants, GABAergic transmission is impaired (loss-of-function). SLITRK3-KO mice show enhanced seizure susceptibility, spontaneous epileptiform EEG, higher motor activity, and reduced parvalbumin interneurons.\",\n      \"method\": \"Immunostaining of HEK-293 cells expressing patient variants, primary hippocampal neuron electrophysiology, SLITRK3-KO mouse phenotyping (EEG, PTZ-induced seizure, immunohistochemistry for parvalbumin)\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — patient variant functional characterization with orthogonal assays (cell biology, electrophysiology, in vivo mouse model)\",\n      \"pmids\": [\"38495551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SLITRK3 is an integral membrane protein with two leucine-rich repeat (LRR) domains and a C-terminal domain partially similar to Trk neurotrophin receptors. It is expressed predominantly in neural tissue and has neurite-modulating activity in cultured neuronal cells.\",\n      \"method\": \"Sequence/domain analysis, expression profiling, neurite outgrowth assay in cultured neuronal cells\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — domain characterization and cell culture functional assay, single lab\",\n      \"pmids\": [\"14557068\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLITRK3 is a postsynaptic transmembrane adhesion molecule with two extracellular LRR domains that selectively organizes GABAergic inhibitory synapses by interacting in trans with presynaptic PTPδ to induce inhibitory presynaptic differentiation, interacting in cis with Neuroligin 2 through their extracellular domains to synergistically promote inhibitory synapse maturation, requiring its intracellular tyrosine Y969 for synaptic function, and interacting with ErbB4 (via ErbB4's RLD domain) and with gephyrin to stabilize postsynaptic GABAergic machinery; loss of SLITRK3 function in mice and humans causes reduced inhibitory synapses, epileptiform activity, and seizure susceptibility.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"Slitrk3 functions as a postsynaptic adhesion molecule that selectively regulates inhibitory synapse development through trans-synaptic interaction with axonal PTPδ. When expressed in fibroblasts, Slitrk3 triggered inhibitory presynaptic differentiation in contacting axons. Recombinant Slitrk3 preferentially localized to inhibitory postsynaptic sites. Slitrk3-deficient mice showed decreased inhibitory (but not excitatory) synapse number and function in hippocampal CA1 neurons, and increased seizure susceptibility.\",\n      \"method\": \"Heterologous cell co-culture synaptogenesis assay, immunostaining, Slitrk3 KO mouse analysis, electrophysiology, recombinant protein localization\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (cell assay, KO mouse, electrophysiology, localization) in a single high-impact study, foundational paper\",\n      \"pmids\": [\"22286174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Slitrk3, as a member of the Slitrk family, is an integral membrane protein with two extracellular leucine-rich repeat (LRR) domains homologous to Slit proteins and an intracellular domain partially homologous to Trk neurotrophin receptors. Overexpression of Slitrk2 and other Slitrk proteins (including Slitrk3) inhibited neurite outgrowth in cultured neuronal cells, with the functional difference between Slitrk1 and Slitrk2–6 residing in their intracellular domains.\",\n      \"method\": \"Overexpression in cultured neuronal cells, deletion analysis of intracellular domains, domain homology characterization\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional assay with deletion analysis, single lab\",\n      \"pmids\": [\"14550773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Slitrks, including Slitrk3, are enriched in postsynaptic densities in rat brains. Slitrk3 requires PTPδ (not PTPσ) to trigger inhibitory synapse formation, establishing isoform-specific LAR-RPTP pairing: PTPσ mediates excitatory and PTPδ mediates inhibitory synaptogenesis by Slitrks. RNAi-mediated knockdown of Slitrks decreased synapse density.\",\n      \"method\": \"Subcellular fractionation, overexpression/RNAi knockdown in neurons, co-culture synaptogenesis assay with LAR-RPTP isoforms\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (fractionation, KD, OE, co-culture), independent replication of Slitrk3-PTPδ specificity\",\n      \"pmids\": [\"23345436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Neuroligin 2 (NL2) and Slitrk3 (ST3) interact directly through their extracellular domains with nanomolar affinity in a cis fashion at postsynaptic inhibitory sites. During neuronal maturation, both NL2 and ST3 are required and act synergistically to promote GABAergic synapse development. Selective perturbation of the NL2-ST3 interaction impairs inhibitory synapse development, disrupts hippocampal network activity, and increases seizure susceptibility.\",\n      \"method\": \"Binding affinity measurements, co-immunoprecipitation, hippocampal neuron culture assays, electrophysiology, in vivo seizure susceptibility testing\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical binding assay plus multiple cellular and in vivo functional readouts, strong mechanistic dissection\",\n      \"pmids\": [\"29107521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LAR-RPTP binding to postsynaptic adhesion ligands including Slitrk3 induces reciprocal higher-order clustering of trans-synaptic adhesion complexes. The crystal structure of the human LAR-RPTP/IL1RAPL1 complex revealed that lateral interactions between neighboring complexes are critical for higher-order assembly and synaptogenic activity. Heparan sulfate (HS) can competitively dismantle pre-established LAR-RPTP–Slitrk3 trans-synaptic complexes.\",\n      \"method\": \"Crystal structure determination, synaptogenesis assay, clustering assay\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — structural data plus functional clustering assay, single study\",\n      \"pmids\": [\"29081732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The conserved tyrosine residue Y969 in the Slitrk3 carboxyl (C)-terminus is critical for GABAergic synapse development in hippocampal neurons. ST3 C-terminus is not required for homo-dimerization or cell-surface trafficking in heterologous cells. In neurons, the Y969A mutant failed to rescue GABAergic transmission deficits in ST3-deleted neurons and markedly reduced gephyrin puncta density.\",\n      \"method\": \"Site-directed mutagenesis, overexpression in hippocampal neurons, single-cell genetic deletion (rescue experiment), electrophysiology, immunostaining\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis with defined single-residue functional readout, rescue experiment with KO neurons, multiple complementary methods\",\n      \"pmids\": [\"31551708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Slitrk3 stabilization at GABAergic synapses during development requires interaction with gephyrin. Protein kinase A–mediated phosphorylation of gephyrin on serine 303 (downstream of GABAAR and A2AR signaling) is required for GABAAR stabilization, and gephyrin–Slitrk3 interaction is involved in the stabilization of both pre- and postsynaptic GABAergic elements.\",\n      \"method\": \"Pharmacological activation/blockade of GABAAR and A2AR, biochemical interaction assays, phosphomutant analysis, imaging of synapse stabilization/elimination\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — interaction and phosphorylation assay with functional consequence, single study for gephyrin-Slitrk3 interaction specifically\",\n      \"pmids\": [\"34735259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ErbB4, via its extracellular RLD domain, interacts in trans with Slitrk3 at inhibitory synapses in a kinase-independent manner to promote inhibitory synapse formation onto pyramidal neurons. Disruption of ErbB4-Slitrk3 interaction (using secretable RLD) decreased inhibitory synapses onto pyramidal neurons and impaired GABAergic transmission.\",\n      \"method\": \"Co-culture HEK293T/neuron synaptogenesis assay, co-immunoprecipitation, kinase-dead knock-in mice, neutralization with secretable RLD domain, electrophysiology\",\n      \"journal\": \"Translational psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus functional co-culture assay and in vivo mouse data, single lab\",\n      \"pmids\": [\"34226493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SLITRK3 activates NTRK3 in lung squamous cell carcinoma (LUSC) cells to promote a cancer stem cell phenotype. Gene amplification drives high SLITRK3 expression in LUSC, and SLITRK3-dependent NTRK3 activation is inhibited by NTRK-targeted inhibitors, reducing the CD133-positive cancer stem cell fraction.\",\n      \"method\": \"In situ immunofluorescence, sphere-formation assay, FACS (CD133+ fraction), copy number and expression analysis of patient datasets\",\n      \"journal\": \"Molecular biomedicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — functional cancer cell assays but mechanism of NTRK3 activation not biochemically resolved, single lab\",\n      \"pmids\": [\"35006496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Biallelic loss-of-function variants (C566R, E606X) in SLITRK3 cause epileptic encephalopathy with microcephaly, intellectual disability, and seizures. C566R and E606X mutations alter SLITRK3 cell-surface expression, causing protein accumulation in the Golgi apparatus. Primary hippocampal neurons carrying patient variants show impaired GABAergic transmission by electrophysiology. SLITRK3 KO mice exhibit spontaneous epileptiform EEG activity, enhanced seizure susceptibility, and reduced parvalbumin interneurons.\",\n      \"method\": \"Immunostaining in HEK-293 cells, primary hippocampal neuron cultures with patient variants, electrophysiology (mIPSC recording), EEG recording in KO mice, pentylenetetrazole seizure threshold assay\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — patient variant functional characterization with multiple orthogonal methods (cell biology, electrophysiology, in vivo EEG), replicated in both human cell and mouse models\",\n      \"pmids\": [\"38495551\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLITRK3 is a postsynaptic transmembrane cell adhesion molecule that selectively organizes inhibitory (GABAergic) synapse development by forming a trans-synaptic complex with presynaptic PTPδ and a cis-interaction with postsynaptic Neuroligin 2; its conserved intracellular tyrosine Y969 is required for synapse function, its extracellular domain also mediates interactions with ErbB4, gephyrin stabilization links it to activity-dependent synapse maintenance, and loss-of-function mutations in humans cause epileptic encephalopathy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SLITRK3 is a postsynaptic transmembrane adhesion molecule that selectively organizes inhibitory GABAergic synapses in the mammalian brain. It contains two extracellular leucine-rich repeat domains and engages presynaptic PTPδ in trans to induce inhibitory presynaptic differentiation, while interacting in cis with Neuroligin 2 through their extracellular domains to synergistically promote inhibitory synapse maturation [PMID:22286174, PMID:29107521]. Intracellularly, a conserved tyrosine (Y969) in its C-terminus is required for GABAergic synapse development, and SLITRK3 interacts with gephyrin and with the RLD domain of ErbB4 to stabilize postsynaptic GABAergic machinery including GABA_A receptors [PMID:31551708, PMID:34735259, PMID:34226493]. Loss-of-function mutations in human SLITRK3 cause protein mislocalization and impaired GABAergic transmission, and SLITRK3-knockout mice exhibit reduced inhibitory synapses, spontaneous epileptiform activity, and enhanced seizure susceptibility [PMID:22286174, PMID:38495551].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Before any synaptic function was known, identification of SLITRK3 as a neural-enriched transmembrane protein with two LRR domains and Trk-like C-terminal homology established it as a candidate neurite-modulating molecule.\",\n      \"evidence\": \"Sequence/domain analysis and neurite outgrowth assay in cultured neuronal cells\",\n      \"pmids\": [\"14557068\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No synaptic function tested\", \"Neurite modulation mechanism not defined\", \"In vivo relevance unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The central question of what SLITRK3 does at synapses was answered: it acts as a postsynaptic adhesion molecule that selectively induces inhibitory presynaptic differentiation through trans-synaptic binding to PTPδ, and its loss causes reduced inhibitory synapses and epileptiform phenotypes in vivo.\",\n      \"evidence\": \"Heterologous co-culture synaptogenesis assay, Slitrk3 KO mouse electrophysiology, EEG, and immunostaining\",\n      \"pmids\": [\"22286174\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Postsynaptic signaling downstream of SLITRK3 unknown\", \"Relationship to other inhibitory synapse organizers undefined\", \"Structural basis of PTPδ selectivity not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Two studies clarified how SLITRK3 cooperates with other synaptic organizers: it forms a nanomolar-affinity cis complex with Neuroligin 2 to synergistically drive GABAergic synapse maturation, and its trans-synaptic complex with LAR-RPTPs undergoes higher-order clustering that can be dismantled by competing heparan sulfate.\",\n      \"evidence\": \"Binding affinity measurements, domain-mapping mutagenesis, co-culture assays, electrophysiology, in vivo seizure assay (NL2–Slitrk3); crystal structure-guided clustering assays (LAR-RPTP/Slitrk3)\",\n      \"pmids\": [\"29107521\", \"29081732\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of NL2–Slitrk3 cis interaction not resolved\", \"Physiological relevance of heparan sulfate competition in vivo not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The intracellular signaling requirement was pinpointed: tyrosine Y969 in the SLITRK3 C-terminus is essential for gephyrin recruitment and GABAergic transmission, even though the C-terminus is dispensable for surface trafficking and homo-dimerization.\",\n      \"evidence\": \"Y969A site-directed mutagenesis with rescue in Slitrk3-KO hippocampal neurons, electrophysiology and immunostaining\",\n      \"pmids\": [\"31551708\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase phosphorylating Y969 not identified\", \"Direct binding partner of the phospho-Y969 motif unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Two additional postsynaptic partners were identified: gephyrin stabilizes both pre- and postsynaptic GABAergic elements through its interaction with SLITRK3 (modulated by PKA-dependent gephyrin S303 phosphorylation), and ErbB4 engages SLITRK3 in trans via its RLD domain to promote inhibitory synapse formation in a kinase-independent manner.\",\n      \"evidence\": \"Co-immunoprecipitation of gephyrin–Slitrk3, PKA pathway pharmacology and phosphomutant analysis (gephyrin); co-culture assay with ΔRLD mutant ErbB4, ErbB4 kinase-dead knock-in mice, Slitrk3 neutralization, electrophysiology\",\n      \"pmids\": [\"34735259\", \"34226493\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs. indirect nature of gephyrin–SLITRK3 binding not resolved with purified components\", \"Whether ErbB4–SLITRK3 and PTPδ–SLITRK3 interactions are mutually exclusive is unknown\", \"Relationship between Y969 phosphorylation and gephyrin binding not established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Outside the nervous system, SLITRK3 was reported to activate NTRK3 signaling in lung squamous cell carcinoma, promoting a cancer stem cell phenotype sensitive to NTRK inhibitors.\",\n      \"evidence\": \"Immunofluorescence, sphere-formation assay, FACS for CD133+ cells, NTRK inhibitor treatment in LUSC cell lines\",\n      \"pmids\": [\"35006496\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct physical interaction between SLITRK3 and NTRK3 not demonstrated\", \"Not validated in vivo or in independent studies\", \"Mechanism of NTRK3 activation by SLITRK3 not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Human disease relevance was established: pathogenic SLITRK3 variants (C566R, E606X) cause Golgi retention and loss of surface expression, impairing GABAergic transmission and recapitulating the seizure-susceptible phenotype of SLITRK3-KO mice, which additionally show reduced parvalbumin interneurons.\",\n      \"evidence\": \"Patient variant expression in HEK-293 cells, hippocampal neuron electrophysiology, SLITRK3-KO mouse EEG, PTZ seizure assay, parvalbumin immunohistochemistry\",\n      \"pmids\": [\"38495551\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Number of human patients/families with confirmed SLITRK3 mutations is limited\", \"Whether parvalbumin interneuron loss is cell-autonomous or circuit-level effect unknown\", \"Therapeutic rescue strategies not explored\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the kinase that phosphorylates Y969, the structural basis of the SLITRK3–Neuroligin 2 cis complex, and whether the multiple trans interactions (PTPδ, ErbB4) are spatially or temporally segregated at inhibitory synapses.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No kinase identified for Y969\", \"No atomic structure of SLITRK3 in any complex\", \"Spatial organization of multiple SLITRK3 trans interactions at single synapses unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 1, 5]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 1, 3, 4, 5]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [0, 1, 2, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PTPRD\", \"NLGN2\", \"GPHN\", \"ERBB4\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"SLITRK3 is a postsynaptic transmembrane adhesion molecule that selectively promotes GABAergic (inhibitory) synapse development and maintenance. Its extracellular leucine-rich repeat domains engage presynaptic PTPδ in trans to trigger inhibitory presynaptic differentiation, while a cis-interaction with Neuroligin 2 at nanomolar affinity synergistically drives inhibitory synapse assembly; heparan sulfate can competitively dismantle the PTPδ–SLITRK3 complex, and ErbB4 provides an additional trans-synaptic input that promotes inhibitory synaptogenesis onto pyramidal neurons [PMID:22286174, PMID:23345436, PMID:29107521, PMID:34226493, PMID:29081732]. Intracellularly, the conserved tyrosine Y969 is required for GABAergic transmission and gephyrin scaffold stabilization, linking activity-dependent PKA-mediated gephyrin phosphorylation to the maintenance of both pre- and postsynaptic inhibitory elements [PMID:31551708, PMID:34735259]. Biallelic loss-of-function SLITRK3 variants cause epileptic encephalopathy with microcephaly, consistent with impaired GABAergic transmission and reduced parvalbumin interneuron numbers observed in SLITRK3 knockout mice [PMID:38495551].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of SLITRK3 as a neuronal transmembrane protein with Slit-like LRR and Trk-like intracellular domains established that the Slitrk family can regulate neurite outgrowth, with functional specificity mapping to the intracellular domain.\",\n      \"evidence\": \"Overexpression and deletion analysis in cultured neuronal cells\",\n      \"pmids\": [\"14550773\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Neurite outgrowth phenotype was shown for Slitrk2 primarily; SLITRK3-specific effect inferred from family membership\",\n        \"Synaptic role not yet explored\",\n        \"Endogenous binding partners unknown\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The discovery that SLITRK3 selectively promotes inhibitory synapse formation via trans-synaptic interaction with PTPδ, and that knockout mice show reduced inhibitory synapses and seizure susceptibility, established SLITRK3 as the first synapse organizer with specificity for inhibitory synapses.\",\n      \"evidence\": \"Heterologous co-culture synaptogenesis assay, immunostaining, Slitrk3 KO mice, electrophysiology\",\n      \"pmids\": [\"22286174\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of PTPδ selectivity unresolved\",\n        \"Postsynaptic signaling downstream of SLITRK3 unknown\",\n        \"Whether other postsynaptic partners contribute not tested\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Independent confirmation that SLITRK3 specifically requires PTPδ (not PTPσ) for inhibitory synaptogenesis, combined with the finding that Slitrks are enriched in postsynaptic densities, solidified the isoform-specific LAR-RPTP pairing model for excitatory versus inhibitory synapse specification.\",\n      \"evidence\": \"Subcellular fractionation, overexpression/RNAi in neurons, co-culture with LAR-RPTP isoforms\",\n      \"pmids\": [\"23345436\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular determinants within PTPδ that confer SLITRK3 specificity not mapped\",\n        \"Role of PTPδ phosphatase activity in downstream signaling unclear\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Two advances revealed the combinatorial logic of inhibitory synapse assembly: SLITRK3 forms a cis-complex with Neuroligin 2 that synergistically drives GABAergic synaptogenesis, and the trans-synaptic LAR-RPTP–ligand complexes undergo higher-order clustering essential for synaptogenic activity, with heparan sulfate capable of dismantling SLITRK3–PTPδ complexes.\",\n      \"evidence\": \"Binding affinity measurements, co-immunoprecipitation, hippocampal neuron cultures, electrophysiology, in vivo seizure testing, crystal structure and clustering assays\",\n      \"pmids\": [\"29107521\", \"29081732\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of the NL2–SLITRK3 cis-interaction not determined\",\n        \"In vivo relevance of heparan sulfate-mediated complex disassembly untested\",\n        \"Stoichiometry and dynamics of higher-order assemblies at native synapses unknown\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of Y969 as a critical intracellular residue for GABAergic synapse function linked SLITRK3's postsynaptic signaling capacity to gephyrin scaffold assembly, showing the C-terminus is dispensable for surface trafficking but essential for synaptic rescue.\",\n      \"evidence\": \"Site-directed mutagenesis, single-cell KO rescue in hippocampal neurons, electrophysiology, immunostaining\",\n      \"pmids\": [\"31551708\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Kinase responsible for Y969 phosphorylation not identified\",\n        \"Direct binding partners of the SLITRK3 intracellular domain beyond gephyrin not characterized\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Three parallel discoveries expanded the SLITRK3 interaction network and its regulation: gephyrin–SLITRK3 interaction stabilizes GABAergic synapses downstream of PKA-mediated gephyrin S303 phosphorylation; ErbB4 provides a kinase-independent trans-synaptic input through its RLD domain to promote inhibitory synaptogenesis; and in a non-neuronal context, SLITRK3 gene amplification in lung squamous cell carcinoma activates NTRK3 to support a cancer stem cell phenotype.\",\n      \"evidence\": \"Pharmacological and phosphomutant assays for gephyrin interaction; co-culture, co-IP, kinase-dead knock-in mice for ErbB4; sphere-formation and FACS for cancer phenotype\",\n      \"pmids\": [\"34735259\", \"34226493\", \"35006496\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Gephyrin–SLITRK3 binding interface not structurally resolved\",\n        \"ErbB4–SLITRK3 interaction confirmed in single lab; reciprocal in vivo genetic validation pending\",\n        \"NTRK3 activation mechanism by SLITRK3 in cancer cells not biochemically defined; single study with low mechanistic resolution\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Biallelic SLITRK3 loss-of-function variants (C566R, E606X) were shown to cause epileptic encephalopathy with microcephaly, directly linking impaired SLITRK3 surface trafficking and GABAergic transmission deficits to human disease; KO mice recapitulated epileptiform activity and reduced parvalbumin interneuron numbers.\",\n      \"evidence\": \"Patient variant functional characterization in HEK-293 cells and primary neurons, mIPSC recording, EEG in KO mice, PTZ seizure threshold assay\",\n      \"pmids\": [\"38495551\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Number of patient families is small; broader genotype–phenotype spectrum not yet defined\",\n        \"Whether C566R retains partial function or is fully null not resolved\",\n        \"Mechanism linking SLITRK3 loss to reduced parvalbumin interneuron count (cell death vs. differentiation failure) unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the kinase(s) phosphorylating Y969, the structural basis of the NL2–SLITRK3 cis-complex, how SLITRK3 signals intracellularly to recruit gephyrin, and whether therapeutic rescue of GABAergic transmission is feasible in SLITRK3-associated epileptic encephalopathy.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No kinase for Y969 identified\",\n        \"No crystal or cryo-EM structure of SLITRK3 intracellular domain or NL2–SLITRK3 cis-complex\",\n        \"Therapeutic strategies for SLITRK3 deficiency not explored\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 2, 9]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 2, 3, 5, 6]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [0, 3, 7]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 6, 7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PTPRD\",\n      \"NLGN2\",\n      \"ERBB4\",\n      \"GPHN\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}